Introduction to Bremelanotide for Research
Bremelanotide is a synthetic peptide analog of the body’s natural alpha‑melanocyte stimulating hormone (α‑MSH). Its structure is a cyclic heptapeptide lactam, Ac‑Nle‑cyclo[Asp‑His‑D‑Phe‑Arg‑Trp‑Lys]‑OH, a design that greatly improves stability and receptor selectivity compared to the linear parent peptide. In controlled laboratory settings, researchers use bremelanotide as a molecular tool to probe the melanocortin receptor family—particularly MC4R and MC1R, both G protein‑coupled receptors involved in a broad array of physiological functions studied in model systems. When sourcing this peptide, securing it from a bremelanotide third party tested supplier is essential to guarantee the identity and purity that reproducible science demands. All products are supplied strictly for laboratory research use; they are not approved for any human or veterinary application, diagnostic procedure, or clinical intervention.
Why Third Party Testing Matters for Research Peptides
Third party testing means sending product samples to an independent, accredited laboratory that has no financial stake in the manufacturer. This extra verification layer delivers several critical assurances to research buyers. First, it validates the peptide’s identity, using mass spectrometry (MS) and amino acid analysis to confirm that the molecule is indeed bremelanotide and not a closely related analog or degradation product. Second, it provides an unbiased measurement of purity—usually by reversed‑phase high‑performance liquid chromatography (HPLC)—and quantifies any residual synthesis‑related impurities such as deletion sequences, diastereomeric peptides, or organic solvents. Third, it confirms the net peptide content and counter‑ion composition, which directly influences the accuracy of stock solution preparation and dose‑response work. A bremelanotide third party tested supplier makes these reports readily available, demonstrating a transparent commitment to quality. Without independent testing, a researcher risks introducing unknown variables that may confound receptor binding data or produce irreproducible cellular responses. Batch‑specific third party certificates also provide the long‑term consistency needed when a study spans multiple orders over months or years.
Key Criteria for Selecting a Bremelanotide Supplier
Lorsqu'on évalue un bremelanotide third party tested supplier, research institutions, pharmaceutical teams, and distributors should examine several technical and logistical factors to protect experimental integrity.
Purity and Impurity Profiles
For most research applications, a purity of ≥98% as measured by HPLC (typically at 220 nm, the absorbance of the peptide bond) is the accepted standard. More sensitive assays—e.g., receptor‑occupancy studies with low‑abundance targets or in vivo protocols where minor contaminants could trigger off‑target effects—may require 99% purity or higher. The third party certificate of analysis (CoA) should list the overall purity and, if any impurity exceeds a reporting threshold, identify the individual peaks. Common impurity types include related‑sequence peptides (truncation or deletion by‑products), epimerized residues, and residual solvents. A rigorous bremelanotide third party tested supplier will specify the analytical methods used: for example, HPLC on a C18 column with a gradient of acetonitrile in water containing 0.1% trifluoroacetic acid, coupled with electrospray ionization time‑of‑flight mass spectrometry (ESI‑TOF MS) for peak identification. The mass spectrum should show the monoisotopic molecular weight of bremelanotide (calculated as 1025.2 g/mol for the neutral form) within a mass accuracy of a few parts per million. Quantitative amino acid analysis or elemental analysis can further verify the net peptide content, because the gross weight of lyophilized powder includes counter‑ions (e.g., acetate, trifluoroacetate) and residual water. Always insist on a batch‑specific certificate—never accept a generic statement that covers all lots without individual data.
Shipping and Handling Documentation
Peptide integrity during transit is just as important as the pre‑shipment quality reading. A reliable supplier supplies a clear chain‑of‑custody record, including the date of synthesis, recommended storage conditions (typically long‑term storage at –20°C in lyophilized form), and guidelines for reconstitution. Bremelanotide is usually shipped as a lyophilized solid; while it is often stable at ambient temperatures for limited periods, a conscientious bremelanotide third party tested supplier will provide forced‑degradation or accelerated‑stability data supporting their chosen shipping method. The Material Safety Data Sheet (MSDS/SDS) must accompany the shipment, describing safe handling, personal protective equipment, and disposal procedures. For international deliveries, accurate customs paperwork—including harmonized system (HS) codes and an explicit declaration of the material’s research‑only status—prevents costly delays. Pre‑shipment documentation that includes a copy of the third party CoA and a statement of the transport conditions ensures the receiving laboratory can immediately verify that the peptide arrived under acceptable parameters.
How to Interpret a Third Party Testing Certificate
A meaningful third party certificate for bremelanotide contains several elements that purchasers should systematically review. First, check the testing laboratory’s accreditation; ISO/IEC 17025 specifically for peptide or analytical chemistry scope confirms that the lab follows internationally recognized quality‑management standards. The certificate must state the report date, the unique batch or lot number of the peptide, and the name (or digital signature) of the responsible analyst. Method references are crucial: the HPLC section should detail the column stationary phase, mobile phase gradient, and detection wavelength; the mass spectrometry section should describe the ionization source (e.g., ESI) and mass analyzer (e.g., TOF or Orbitrap). The measured purity must appear as a percentage, ideally with the integrated chromatogram showing the main peak and any integration‑related details. For identity, the observed monoisotopic mass must be compared with the theoretical value. Mass error, expressed in ppm, should be within the instrument’s stated specification. A bremelanotide third party tested supplier that provides only a “pass/fail” verdict without the raw analytical data does not give the transparency needed for rigorous documentation. Moreover, the supplier should be able to provide batch‑specific certificates that can be cross‑referenced directly with the testing laboratory, either through a verified online portal or by confirming the lab’s contact information.
Research Applications of Bremelanotide
In basic research, bremelanotide is employed exclusively as a pharmacological probe to explore melanocortin receptor function. The following examples represent typical laboratory investigation directions, all of which occur under approved institutional research protocols:
- Melanocortin Receptor Signaling Studies: Bremelanotide shows high affinity for MC4R and MC1R, with lower activity at MC3R and MC5R. Researchers use it to activate the Gs‑cAMP‑protein kinase A cascade, quantify β‑arrestin recruitment, or measure changes in downstream gene expression in transfected cell lines or primary neuronal cultures.
- Energy Homeostasis and Metabolic Profiling: Because MC4R is a central regulator of appetite and energy expenditure in rodent models, bremelanotide is applied to dissect hypothalamic circuits. Such studies expand fundamental knowledge of metabolic regulation without entering any application domain.
- Pharmacological Characterization of Novel Compounds: Thanks to its well‑defined structure‑activity relationship, bremelanotide serves as a positive control in competitive binding assays, calcium flux measurements, or cAMP accumulation tests when screening new MC4R agonists or antagonists.
- Receptor Trafficking and Imaging: Fluorescently tagged or biotinylated analogs of bremelanotide are utilized to track receptor internalization, recycling, and potential heterodimerization between melanocortin receptor subtypes in live‑cell imaging studies.
All uses of the peptide are limited strictly to laboratory research. It is not intended for any human or veterinary purpose, nor for diagnostic or clinical investigation.
Conclusion: Sourcing with Confidence
Choosing a bremelanotide third party tested supplier is a foundational step in safeguarding the reproducibility and integrity of your research data. Prioritize suppliers who openly share ISO/IEC 17025‑accredited third party certificates, batch‑specific purity and impurity profiles, and complete shipping documentation. A direct relationship with the supplier’s technical support team can help clarify synthetic routes, residual solvent levels, and optimal reconstitution conditions for your specific assays. Verify each certificate by checking the testing laboratory’s accreditation status and, when possible, confirming the certificate’s authenticity with the issuing lab. A dependable partner will also offer logistical guidance—ensuring that the lyophilized peptide is transported under conditions that match the stability data and that all import documents reflect the product’s research‑only status. With rigorous supplier evaluation, laboratories can consistently obtain a high‑quality melanocortin tool that supports robust, publishable outcomes.
Remarque : à usage strictement scientifique : All bremelanotide products mentioned are intended exclusively for laboratory research. They are not for use in humans, in any diagnostic or clinical procedure, or for any veterinary purpose. Researchers are responsible for complying with all applicable national and institutional regulations when handling this peptide.
Réservé à la recherche. Ne pas utiliser chez l'homme ni chez les animaux.
